Background And Purpose: The biosynthesis of leukotrienes (LT) and platelet-activating factor (PAF) involves the release of their respective precursors, arachidonic acid (AA) and lyso-PAF by the group IVA PLA2 (cPLA2alpha). This paper aims at characterizing the inhibitory properties of the cPLA2alpha inhibitor pyrrophenone on eicosanoids and PAF in human neutrophils (PMN).
Experimental Approach: Freshly isolated human PMN were activated with physiological and pharmacological agents (fMLP, PAF, exogenous AA, A23187 and thapsigargin) in presence and absence of the cPLA2alpha inhibitor pyrrophenone and biosynthesis of LT, PAF, and PGE2 was measured.
Key Results: Pyrrophenone potently inhibited LT, PGE2 and PAF biosynthesis in PMN with IC50s in the range of 1-20 nM. These inhibitory effects of pyrrophenone were specific (the consequence of substrate deprivation), as shown by the reversal of inhibition by exogenous AA and lyso-PAF. Comparative assessment of pyrrophenone, methyl-arachidonoyl-fluoro-phosphonate (MAFP) and arachidonoyl-trifluoromethylketone (AACOCF3) demonstrated that pyrrophenone was more specific and 100-fold more potent than MAFP and AACOCF3 for the inhibition of LT biosynthesis in A23187-activated PMN. The inhibitory effect of pyrrophenone on LT biosynthesis was reversible as LT biosynthesis was recovered when pyrrophenone-treated PMN were washed with autologous plasma. No alteration of phospholipase D (PLD) activity in fMLP-activated PMN was observed with up to 10 microM pyrrophenone, suggesting that the cPLA2alpha inhibitor does not directly inhibit PLD.
Conclusions And Implications: Pyrrophenone is a more potent and specific cPLA2alpha inhibitor than MAFP and AACOCF3 and represents an excellent pharmacological tool to investigate the biosynthesis and the biological roles of eicosanoids and PAF.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978440 | PMC |
| http://dx.doi.org/10.1038/sj.bjp.0706879 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Next generation thiazolyl ketone inhibitors of cytosolic phospholipase A α for targeted cancer therapy.
Nat Commun
January 2025
Department of Biology, Norwegian University of Science and Technology, Trondheim, Norway.
Eicosanoids are key players in inflammatory diseases and cancer. Targeting their production by inhibiting Group IVA cytosolic phospholipase A (cPLAα) offers a promising approach for cancer therapy. In this study, we synthesize a second generation of thiazolyl ketone inhibitors of cPLAα starting with compound GK470 (AVX235) and test their in vitro and cellular activities.
View Article and Find Full Text PDFStudy on the anti-inflammatory mechanism of moxibustion in rheumatoid arthritis in rats based on phospholipaseA2 signaling inhibition by Annexin 1.
J Tradit Chin Med
August 2024
Department of Acupuncture-Moxibustion and Tuina, the Third Affiliated Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Article Synopsis
- The study aimed to evaluate the anti-inflammatory effects of moxibustion on rheumatoid arthritis (RA) by analyzing its impact on Annexin 1 expression and the phospholipase A2 signaling pathway.
- Thirty male rats were divided into five groups to test various treatments, including moxibustion and Annexin 1 interference, following the induction of RA with Freund's complete adjuvant.
- Results indicated that moxibustion enhanced Annexin 1 levels, reduced inflammation, and positively influenced various inflammatory markers in the rats, suggesting its potential therapeutic role in RA.
-Disubstituted 4-Sulfamoylbenzoic Acid Derivatives as Inhibitors of Cytosolic Phospholipase A: Synthesis, Aqueous Solubility, and Activity in a Vesicle and a Whole Blood Assay.
Med Chem
October 2024
Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Corrensstrasse 48, 48149 Münster, Germany.
Background: Cytosolic phospholipase A2α (cPLA) is the key enzyme that initiates the arachidonic acid cascade through which pro-inflammatory lipid mediators can be formed. Therefore, cPLA is considered an interesting target for the development of anti-inflammatory drugs. Although several effective inhibitors of the enzyme have been developed, none of them has yet reached clinical application.
View Article and Find Full Text PDFDesign, synthesis of ceramide 1-phosphate analogs and their affinity for cytosolic phospholipase A as evidenced by surface plasmon resonance.
Bioorg Med Chem Lett
July 2024
Department of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan; Forefront Research Center, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan.
Ceramide 1-phosphate (C1P) is a lipid mediator that specifically binds and activates cytosolic phospholipase Aα (cPLAα). To elucidate the structure-activity relationship of the affinity of C1P for cPLAα in lipid environments, we prepared a series of C1P analogs containing structural modifications in the hydrophilic parts and subjected them to surface plasmon resonance (SPR). The results suggested the presence of a specific binding site for cPLAα on the amide, 3-OH and phosphate groups in C1P structure.
View Article and Find Full Text PDF1-Benzylindoles as inhibitors of cytosolic phospholipase Aα: synthesis, biological activity, aqueous solubility, and cell permeability.
RSC Med Chem
February 2024
Institute of Pharmaceutical and Medicinal Chemistry, University of Münster Corrensstrasse 48 48149 Münster Germany
Cytosolic phospholipase Aα (cPLAα) is considered an interesting target for the development of new anti-inflammatory drugs, as it is significantly involved in the formation of pro-inflammatory lipid mediators. Recently, in a ligand-based virtual screening approach, 2,4-dichlorobenzyl-substituted 4-[2-(indol-3-ylmethylene)hydrazineyl]benzoic acid 7 was found to be an inhibitor of cPLAα with micromolar activity. This compound has now been systematically varied to increase inhibitory potency.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!